SEARCH

SEARCH BY CITATION

Bibliography

  • 1
    Malchow H, Ewe K & Brandes JW, et al. European Cooperative Crohn’s Disease Study (ECCDS): results of drug treatment. Gastroenterology 1984; 86: 24966.
  • 2
    Summers RW, Switz DM & Sessions JT, et al. National Cooperative Crohn’s Disease Study: results of drug treatment. Gastroenterology 1979; 77: 84769.
  • 3
    Munkholm P, Langholz E, Davidsen M & Binder V. Frequency of glucocorticoid resistance and dependency in Crohn’s disease. Gut 1994; 35: 3602.
  • 4
    Lukert BP & Raisz LG. Glucocorticoid-induced osteoporosis: pathogenesis and management. Ann Intern Med 1990; 112: 32564.
  • 5
    Adachi JD, Bensen WG & Hodsman AB. Corticosteroid-induced osteoporosis. Semin Arthritis Rheum 1993; 22: 37584.
  • 6
    Caldwell JR & Furst DE. The efficacy and safety of low-dose corticosteroids for rheumatoid arthritis. Semin Arthritis Rheum 1991; 21: 111.
  • 7
    Tripathi RC, Kirschner BS & Kipp M, et al. Corticosteroid treatment for inflammatory bowel disease in pediatric patients increases intraocular pressure. Gastroenterology 1992; 102: 195761.
  • 8
    Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ & Wilske KR. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Int Med 1989; 110: 3536.
  • 9
    Chamiot-Prieur C, Lémann M & Mesnard B, et al. Treatment of refractory Crohn’s disease with methotrexate. Gastroenterology 1993; 104: A680A680(Abstract).
  • 10
    Baron TH, Truss CD & Elson CO. Low-dose oral methotrexate in refractory inflammatory bowel disease. Dig Dis Sci 1993; 38: 18516.
  • 11
    Arora S, Katkov W & Cooley J, et al. Methotrexate in Crohn’s disease: results of a randomized, double-blind, placebo-controlled trial. Hepatogastroenterology 1999; 46: 17249.
  • 12
    Feagan BG, Rochon J & Fedorak RN, et al. Methotrexate for the treatment of Crohn’s disease. N Engl J Med 1995; 332: 2927.
  • 13
    Oren R, Moshkowitz M & Odes S, et al. Methotrexate in chronic active Crohn’s disease: a double-blind, randomized, Israeli multicenter trial. Am J Gastroenterol 1997; 92: 22039.
  • 14
    Feagan BG, Fedorak RN & Irvine EJ, et al. A comparison of methotrexate with placebo for the maintenance of remission in Crohn’s disease. North America Crohn’s Study Group Investigators. N Engl J Med 2000; 342(22): 162732.
  • 15
    Lemann M, Zenjari T & Bouhnik Y, et al. Methotrexate in Crohn’s disease: long-term efficacy and toxicity. Am J Gastroenterol 2000; 95(7): 17304.
  • 16
    Zenjari T, Lemann M & Mesnard B, et al. Methotrexate in Crohn’s disease: long term efficacy and toxicity. Gastroenterology 1996; 110: A1053A1053(Abstract).
  • 17
    Kozerak RA, Patterson DJ, Gelfand MD, Ball TJ & Botoman VA. Long-term use of methotrexate in inflammatory bowel disease: severe disease 3, drug therapy 2. seventh inning stretch. Gastroenterology 1996; 102: A648A648(Abstract).
  • 18
    Mahadevan U, Marion JF & Present DH. The place for methotrexate in the treatment of refractory Crohn’s disease. Gastroenterology 1997; 112(4): A1031A1031(Abstract).
  • 19
    Vandeputte L, D’Haens G, Baert F & Rutgeerts P. Methotrexate in refractory Crohn’s disease. Inflamm Bowel Dis 1999; 5(1): 115.
  • 20
    Egan LJ & Sandborn WJ. Methotrexate for inflammatory bowel disease: pharmacology and preliminary results. Mayo Clin Proc 1996; 71: 6980.
  • 21
    Alvarez F, Dallavis J & O’Brien J. The role of methotrexate therapy in the management of patients with cyclosporine A-resistant inflammatory bowel disease. Gastroenterology 1996; 110: A853A853(Abstract).
  • 22
    Lémann M, Chamiot-Prieur C & Mesnard B, et al. Methotrexate for the treatment of refractory Crohn’s disease. Aliment Pharmacol Ther 1996; 10: 30914.
  • 23
    Mack DR, Young R, Kaufman SS, Ramey L & Vanderhoof JA. Methotrexate in patients with Crohn’s disease after 6 mercaptopurine. J Pediatr 1998; 132(5): 8305.
  • 24
    Cheetman BC & Harris MS. Efficacy and safety of subcutaneous methotrexate in Crohn’s disease. Gastroenterology 1995; 108: A796A796(Abstract).
  • 25
    Gohkale R & Kirshner BS. Methotrexate therapy in children with severe Crohn’s disease: preliminary results. Gastroenterology 1996; 110: A916A916(Abstract).
  • 26
    Te HS, Schiano TD & Hanauer SB, et al. Hepatic effects of long-term methotrexate therapy of inflammatory bowel disease. Hepatology 1998; 28(4): A434A434(Abstract).